Inactivity Duration on Lipid Metabolism
Public ClinicalTrials.gov record NCT06033898. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effect of the Physical Inactivity Duration on Postprandial Lipid Metabolism the Morning After Exercise
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to investigate the effect of different periods of physical inactivity on postprandial lipid metabolism in the morning after exercise by measuring plasma triglyceride levels and fat oxidation (burning). The study is a crossover intervention with all healthy participants performing three trials varying in length of physical inactive (12 hours, 24 hours, and 36 hours). All trials include a physical activity control phase (\>10,000 steps/24hr), a physical inactive phase (\<1,000 - 1,500 steps/12hr), a moderate intensity cycling session, and a high-fat tolerance test.
Study identification
- NCT ID
- NCT06033898
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 8 participants
Conditions and interventions
Conditions
Interventions
- 12 hours of physical inactivity Behavioral
- 24 hours of physical inactivity Behavioral
- 36 hours of physical inactivity Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2023
- Primary completion
- May 11, 2024
- Completion
- May 11, 2024
- Last update posted
- Mar 2, 2025
2023 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The University of Texas at Austin | Austin | Texas | 78712 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Metabolism trials
Other public records listing Metabolism. Sorted by last update posted; newest first. Not a recommendation.
- NCT04055428: NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals Recruiting
- NCT06320951: VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway Not yet recruiting
- NCT02087826: Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS Active, not recruiting
- NCT06930976: Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells Recruiting
- NCT06813261: GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women Recruiting
- NCT07096011: Studying Phenotypic Risks for Obesity and Underlying Traits in Young Infants Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06033898, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 2, 2025 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06033898 live on ClinicalTrials.gov.